Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27K Sell
96
-247
-72% -$62.2K 0.01% 280
2026
Q1
$83.1K Hold
343
0.02% 185
2025
Q4
$102K Hold
343
0.02% 185
2025
Q3
$96.8K Hold
343
0.02% 173
2025
Q2
$101K Buy
343
+90
+36% +$23.2K 0.03% 166
2025
Q1
$62.9K Buy
253
+5
+2% +$1.22K 0.02% 173
2024
Q4
$54.5K Hold
248
0.02% 180
2024
Q3
$54.8K Sell
248
-20
-7% -$3.92K 0.02% 182
2024
Q2
$46.4K Sell
268
-90
-25% -$15.6K 0.01% 179
2024
Q1
$68.4K Buy
358
+258
+258% +$47.1K 0.02% 174
2023
Q4
$16.4K Sell
100
-140
-58% -$21.2K 0.01% 227
2023
Q3
$33.7K Sell
240
-360
-60% -$51.2K 0.02% 172
2023
Q2
$80.3K Buy
+600
New +$77.4K 0.04% 114
2022
Q3
Sell
-40
Closed -$6K 282
2022
Q2
$6K Buy
40
+36
+900% +$4.86K ﹤0.01% 264
2022
Q1
$1K Buy
+4
New +$522 ﹤0.01% 334

Other funds holding IBM

GoalVest Advisory's IBM Position: Q2 2026 in Review

GoalVest Advisory reduced its IBM (IBM) stake by 72% in Q2 2026, selling an estimated $62.2K and leaving 96 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #280.

GoalVest Advisory first reported a position in IBM in Q1 2022 and has held it in 15 quarters since. The position peaked at $102K in Q4 2025. 1,810 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • GoalVest Advisory held 96 shares of IBM worth $27K as of Q2 2026.
  • GoalVest Advisory sold 247 IBM shares in Q2 2026, an estimated $62.2K.
  • IBM made up 0.01% of GoalVest Advisory's portfolio in Q2 2026, its #280 holding.
  • GoalVest Advisory first reported a position in IBM in Q1 2022 and has held it in 15 quarters since.
  • GoalVest Advisory's IBM position peaked at $102K in Q4 2025.
  • 1,810 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on GoalVest Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.